The therapeutic industry's reliance on high-quality intermediates is paramount, driving significant requirement for both large-scale bulk distribution and specialized custom creation services. Many firms are finding it increasingly helpful to outsource these complex processes, allowing them to dedicate resources on core research and innovation. Bul